AIDS Funding Increased for Fiscal '97

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 11
Volume 5
Issue 11

WASHINGTON-Federal AIDS programs faired well in the budget bill passed by Congress and signed by President Clinton, which included increased funding in fiscal year 1997 for research, prevention, care, and drug assistance.

WASHINGTON—Federal AIDS programs faired well in the budget bill passed by Congress and signed by President Clinton, which included increased funding in fiscal year 1997 for research, prevention, care, and drug assistance.

The legislation provided the Department of Health and Human Services, which funds the vast majority of AIDS projects, with $3.213 billion for its AIDS programs outside of Medicare and Medicaid. This represents a 12.4% increase over the $2.856 billion provided in fiscal 1996, according to the White House Office of National AIDS Policy.

The legislation upped funding for programs that help HIV patients purchase drugs to $167 million, an increase of 221%; increased AIDS research funding at NIH to $1.5 billion, a 6.7% increase; and provided $617 million for AIDS prevention programs, a 6% increase.

Recent Videos
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Despite CD19 CAR T-cell therapy exhibiting efficacy in patients with relapsed/refractory large B-cell lymphoma, less than half achieve long-term remission.
4 experts in this video
4 experts in this video
Related Content